Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.

Lerdkiattikorn, Panattharin; Chaikledkaew, Usa; Lausoontornsiri, Wirote; Chindavijak, Somjin; Khuhaprema, Thirawud; Tantai, Narisa; Teerawattananon, Yot

doi:10.1586/14737167.2015.972379

Record: found
Abstract: found
Article: not found

Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.

Author(s): Panattharin Lerdkiattikorn, Usa Chaikledkaew, Wirote Lausoontornsiri, Somjin Chindavijak, Thirawud Khuhaprema, Narisa Tantai, Yot Teerawattananon

Publication date: 2015

Journal: Expert review of pharmacoeconomics & outcomes research

Publisher: Informa UK Ltd.

Keywords: stage III colon cancer, Thailand, adjuvant chemotherapy, cost-utility analysis, oxaliplatin

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection.

Related collections

Author and article information

Journal

PubMed ID:: 25327502

DOI:: 10.1586/14737167.2015.972379

Keywords: stage III colon cancer,Thailand,adjuvant chemotherapy,cost-utility analysis,oxaliplatin

Data availability:

Keywords: stage III colon cancer, Thailand, adjuvant chemotherapy, cost-utility analysis, oxaliplatin

Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.

Read this article at

Abstract

Related collections

Model Reduction of Parametrized Systems 2015

Author and article information

Journal

Comments

Comment on this article

Cited by 4